REpiCGO (“Réseau Epigénétique du Cancéropôle Grand-Ouest”) is a scientific network composed by internationally recognized teams in the field of epigenetics/cancer interplay and localize in the " Grand Ouest" area of France (i.e. regions Bretagne, Centre, Pays de la Loire, Poitou-Charentes).

REpiCGO officially started in february 2014.

The two major objectives of REpiCGO are to :

• Identify epigenetic marks or actors having a theranostic value in cancer.
• Design and/or develop of new epigenetic therapeutic strategies to limit the cancer development, prevent relapse and/or increase the efficiency of conventional anti-cancer therapies.

Thus, our studies of cancer epigenetics could be promising for expanding the range oftherapeutic opportunities for personalized medicine.